1. PEG-liposomal oxaliplatin combined with nuclear factor-κB inhibitor (PDTC) induces apoptosis in human colorectal cancer cells
   CHUANG YANG et al, 2014, Oncology Reports CrossRef
2. Nanoliposomal oxaliplatin ameliorates chemotherapy-induced neuropathy
   Maryam Alaei et al, 2023, Neuroscience Letters CrossRef
3. Analysis of survival and morphometric parameters of loach embryos and prelarvae under the action of the polyethyleneglycol derivative polymeric nanocarrier
   null null et al, 2024, Studia Biologica CrossRef
4. Nuciferine Attenuates Doxorubicin-Induced Cardiotoxicity: An In Vitro and In Vivo Study
   Rajendran Harishkumar et al, 2021, Cardiovascular Toxicology CrossRef
5. Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells’ survival by protecting cells from oxidative stress
   Weidong Lu et al, 2014, Molecular and Cellular Biochemistry CrossRef
6. Itraconazole halts hepatocellular carcinoma progression by modulating sonic hedgehog signaling in rats: A novel therapeutic approach
   Osama A. Mohammed et al, 2024, Pathology - Research and Practice CrossRef
7. Liposomal delivery and polyethylene glycol-liposomal oxaliplatin for the treatment of colorectal cancer (Review)
   CHUANG YANG et al, 2014, Biomedical Reports CrossRef
8. Nanocarrier System for Increasing the Therapeutic Efficacy of Oxaliplatin
   Negin Alavi et al, 2022, Current Cancer Drug Targets CrossRef
9. Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs
   Gang Wang et al, 2015, Expert Opinion on Drug Delivery CrossRef
10. Targeted delivery of bee venom to A549 lung cancer cells by PEGylate liposomal formulation: an apoptotic investigation
    Samireh Badivi et al, 2024, Scientific Reports CrossRef
11. Hyaluronic acid‐decorated liposomal nanoparticles for targeted delivery of 5‐fluorouracil into HT‐29 colorectal cancer cells
    Behzad Mansoori et al, 2020, Journal of Cellular Physiology CrossRef
12. Luteolin Suppresses the Proliferation of Gastric Cancer Cells and Acts in Synergy with Oxaliplatin
    Li-Qun Ren et al, 2020, BioMed Research International CrossRef
13. A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer
    Stéphanie Durand et al, 2017, BMC Genomics CrossRef
14. Enhancing the efficacy of letrozole-loaded PEGylated nanoliposomes against breast cancer cells: In vitro study
    Soraya Shahbazi et al, 2024, Heliyon CrossRef
15. Biocompatible tumor micro-environment responsive CS-g-PNIPAAm co-polymeric nanoparticles for targeted Oxaliplatin delivery
    Archana S. Patil et al, 2018, Journal of Polymer Research CrossRef
16. Biomaterial-based drug delivery systems used to improve chemotherapeutic activity of pharmaceuticals and to target inhibitors of apoptosis proteins
    Yung-Chih Kuo et al, 2020, Journal of the Taiwan Institute of Chemical Engineers CrossRef
17. The Effect of Liposomal Diallyl Disulfide and Oxaliplatin on Proliferation of Colorectal Cancer Cells: In Vitro and In Silico Analysis
    Faris Alrumaihi et al, 2022, Pharmaceutics CrossRef
18. Nanoparticles Containing Oxaliplatin and the Treatment of Colorectal Cancer
    Hanie Mahaki et al, 2023, Current Pharmaceutical Design CrossRef